Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

about

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway

P2860

Q58775646-3E60119C-983A-4425-8BD1-E502D3DCA940

P2860

Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

Item

http://www.wikidata.org/entity/Q38635672

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Metformin Synergistically Pote ...... nib in Colorectal Cancer Cells

@en

type

Item

label

Metformin Synergistically Pote ...... nib in Colorectal Cancer Cells

@en

prefLabel

Metformin Synergistically Pote ...... nib in Colorectal Cancer Cells

@en

P1476

Metformin Synergistically Pote ...... nib in Colorectal Cancer Cells

@en

P2093

Deokbae Park

http://www.w3.org/2001/XMLSchema#string

Jaeryun Lee

http://www.w3.org/2001/XMLSchema#string

Youngki Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

Methods in mammalian autophagy research

Targeting cancer with small molecule kinase inhibitors

Metformin and reduced risk of cancer in diabetic patients

Growth inhibition by STI571 in combination with radiation in human chronic myelogenous leukemia K562 cells.

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

P304

139-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12717/DR.2017.21.2.139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28785735

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

metformin

P932

5532306

http://www.w3.org/2001/XMLSchema#string

Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

about

P2860

P2860

Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932